Macitentan
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 513 publications
Unrepaired Truncus Arteriosus Type 1 With Eisenmenger Syndrome and Recurrent Embolic Strokes: An Adult Case Report.
Journal: The American journal of case reports
Published: March 11, 2026
Corrigendum to "Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO)" [Vascular Pharmacology 162 (2026) 107585].
Journal: Vascular pharmacology
Published: February 26, 2026
Macitentan and phosphodiesterase-5 inhibitor alone or in combination in newly diagnosed pulmonary arterial hypertension: a pooled analysis.
Journal: JHLT open
Published: January 22, 2026
A Real-World Disproportionality Analysis of Drug-Induced Heart Failure: Integrating FAERS Database and AHA Statement.
Journal: Cardiovascular toxicology
Published: December 28, 2025
Macitentan vs Standard of Care in Pediatric Pulmonary Arterial Hypertension (TOMORROW): A Randomized Clinical Trial.
Journal: The Journal of pediatrics
Published: November 18, 2025
Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO).
Journal: Vascular pharmacology
Published: November 13, 2025
Long-Term Treatment with Single-Tablet Combination of Macitentan and Tadalafil in Pulmonary Arterial Hypertension: Results from A DUE and Its Open-Label Period.
Journal: Advances in therapy
Published: November 11, 2025
Preferences for pulmonary arterial hypertension (PAH) medications: plain language summary on insights from interviews with patients and doctors in the A DUE phase 3 clinical study.
Journal: Future cardiology
Published: November 04, 2025
Acute Decompensated Heart Failure in a Woman With Eisenmenger Syndrome: A Case Report.
Journal: Cureus
Published: October 25, 2025
The Involvement of the Peptidergic Systems in Breast Cancer Development.
Journal: Cancers
Published: October 07, 2025
Endothelin-1 in the failing Fontan: pathobiology, precision therapeutics, and future trial design.
Journal: Frontiers in pediatrics
Published: October 03, 2025
Last Updated: 04/28/2026